Advertisement
Screener

Q32 Bio Inc. (QTTB) Net Income (Loss) Available to Common Stockholders, Basic

2.0 / 5 stars · 20/50 Roast Me

Q32 Bio Inc. Net Income (Loss) Available to Common Stockholders, Basic

Q32 Bio Inc. (QTTB) reported Net Income (Loss) Available to Common Stockholders, Basic of -$8.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-05

  • Q32 Bio Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$8.95M.
  • Q32 Bio Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$7.61M.
  • Q32 Bio Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was $27.94M, a 16.59% decline year-over-year.
  • Q32 Bio Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$7.39M.
  • Q32 Bio Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was $29.82K.
  • Q32 Bio Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$47.73K.
  • Q32 Bio Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$53.74K.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month
2026-06-30-$8.95M
10-Q · filed 2026-08-05
-$16.55M
10-Q · filed 2026-08-05
$11.38M
derived: sum of 3 quarters · filed 2026-08-05
$3.99M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$7.61M
10-Q · filed 2026-05-05
$20.33M
derived: sum of 2 quarters · filed 2026-05-05
$12.94M
derived: sum of 3 quarters · filed 2026-05-05
$3.45M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$27.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$20.55M
derived: sum of 2 quarters · filed 2026-03-10
$11.06M
derived: sum of 3 quarters · filed 2026-08-05
$29.82K
10-K · filed 2026-03-10
2025-09-30-$7.39M
10-Q · filed 2025-11-13
-$16.88M
derived: sum of 2 quarters · filed 2026-08-05
-$27.91M
10-Q · filed 2025-11-13
$5.59M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$9.49M
10-Q · filed 2026-08-05
-$20.52M
10-Q · filed 2026-08-05
$12.98M
derived: sum of 3 quarters · filed 2026-08-05
-$4.62M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$11.03M
10-Q · filed 2026-05-05
$22.47M
derived: sum of 2 quarters · filed 2026-05-05
$4.87M
derived: sum of 3 quarters · filed 2026-05-05
-$12.11M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$33.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$15.90M
derived: sum of 2 quarters · filed 2026-03-10
-$1.08M
derived: sum of 3 quarters · filed 2026-03-10
-$47.73K
10-K · filed 2026-03-10
2024-09-30-$17.59M
10-Q · filed 2025-11-13
-$34.57M
derived: sum of 2 quarters · filed 2025-11-13
-$33.54M
10-Q · filed 2025-11-13
-$6.92M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$16.98M
10-Q · filed 2025-08-06
-$15.95M
10-Q · filed 2025-08-06
$10.67M
derived: sum of 3 quarters · filed 2025-08-06
-$3.36M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31$1.03M
10-Q · filed 2025-05-08
$27.65M
derived: sum of 2 quarters · filed 2025-05-08
$13.62M
derived: sum of 3 quarters · filed 2025-05-08
$7.81M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$26.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$12.59M
derived: sum of 2 quarters · filed 2025-03-11
$6.78M
derived: sum of 3 quarters · filed 2025-03-11
-$53.74K
10-K · filed 2025-03-11
2023-09-30-$14.03M
10-Q · filed 2024-11-07
-$19.84M
derived: sum of 2 quarters · filed 2024-11-07
-$26.68M
10-Q · filed 2024-11-07
2023-06-30-$5.81M
10-Q · filed 2024-08-08
-$12.64M
10-Q · filed 2024-08-08
2023-03-31-$6.84M
10-Q · filed 2024-05-09